You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 29, 2025

Suppliers and packagers for GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062373 ANDA Baxter Healthcare Corporation 0338-0503-48 100 mL in 1 BAG (0338-0503-48) 1982-09-07
Baxter Hlthcare GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062373 ANDA Baxter Healthcare Corporation 0338-0505-48 100 mL in 1 BAG (0338-0505-48) 1982-09-07
Baxter Hlthcare GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062373 ANDA Baxter Healthcare Corporation 0338-0507-41 50 mL in 1 BAG (0338-0507-41) 1982-09-07
Baxter Hlthcare GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062373 ANDA Baxter Healthcare Corporation 0338-0507-48 100 mL in 1 BAG (0338-0507-48) 1982-09-07
Baxter Hlthcare GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062373 ANDA Baxter Healthcare Corporation 0338-0509-41 50 mL in 1 BAG (0338-0509-41) 1982-09-07
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Gentamicin Sulfate in Sodium Chloride 0.9% in Plastic Container

Last updated: July 30, 2025


Introduction

Gentamicin sulfate in sodium chloride 0.9% solution, commonly known as Gentamicin sulfate injection, is a critical antibiotic used globally to treat severe bacterial infections. Its pharmaceutical formulation in a plastic container, typically a bag or bottle, ensures ease of administration, stability, and sterile delivery. The global demand for this drug, driven by its efficacy against Gram-negative infections, prompts a robust supply chain comprising numerous manufacturers and suppliers. This report examines the prominent suppliers, their capabilities, regulatory standings, and market positioning within this niche.


Major Manufacturers of Gentamicin Sulfate in Sodium Chloride 0.9%

1. Fresenius Kabi

Fresenius Kabi is a leading global healthcare company specializing in sterile injectable medicines, infusion solutions, and clinical nutrition. Their portfolio includes generic antibiotics like gentamicin sulfate. Renowned for quality manufacturing standards, the company supplies gentamicin in various forms, including sterile solutions in plastic containers suitable for intravenous administration.

  • Production Facilities: Europe, India, and Asia-Pacific.
  • Regulatory Compliance: FDA, EMA, ISO standards.
  • Market Presence: Extensive distribution networks across North America, Europe, Asia.

2. Hospira (A Pfizer Company)

Hospira has historically been a key player in sterile injectable drugs, including gentamicin sulfate formulations. After acquired by Pfizer, its manufacturing and distribution capabilities expanded, bolstering the global supply of injectable antibiotics.

  • Product Range: Gentamicin sulfate in pre-filled plastic containers.
  • Regulatory Compliance: WHO-GMP, FDA approval.
  • Availability: Predominantly in North America and emerging markets.

3. Sun Pharma

Sun Pharma, India’s largest pharmaceutical company, produces a wide array of injectable antibiotics, including gentamicin sulfate solutions. It leverages low manufacturing costs and robust export markets, especially in Asia, Africa, and Latin America.

  • Manufacturing Sites: India, with multiple WHO-GMP certified plants.
  • Regulatory Approvals: DCGI, FDA, EMA where applicable.
  • Market Reach: Asia, Africa, Latin America, and select European markets.

4. Sandoz (Novartis Division)

Sandoz specializes in generic pharmaceuticals, including injectable antibiotics like gentamicin sulfate. Their manufacturing adheres to strict quality standards, ensuring global distribution.

  • Facilities: Europe, North America, and emerging markets.
  • Regulatory Status: GMP certified, WHO prequalified for some markets.
  • Distribution: Global, with a focus on hospital and long-term care markets.

5. Neopharma

Based in the UAE, Neopharma manufactures sterile injectable antibiotics, including gentamicin sulfate in sodium chloride 0.9%. The company emphasizes regulatory compliance and quality assurance.

  • Manufacturing Locations: UAE, India.
  • Global Reach: Middle East, Africa, South Asia.
  • Regulatory Approvals: Emphasis on GCC, WHO-GMP certification.

Emerging and Regional Suppliers

  • YiChang Huaxin Pharmaceutical: China-based producer with GMP-certified products, expanding into export markets.
  • Tianjin Chase Sun Pharmaceutical: Chinese manufacturer with a significant regional presence and increasing global footprint.
  • Biopharmaco: Latin American manufacturer serving regional markets with WHO-GMP certified facilities.

Key Considerations in Supplier Selection

When evaluating suppliers for gentamicin sulfate in sodium chloride 0.9% in plastic containers, several factors merit attention:

  • Regulatory Compliance: Ensuring suppliers adhere to WHO-GMP, FDA, EMA, and other pertinent standards is non-negotiable for quality assurance.
  • Manufacturing Capacity: Suppliers with scalable production can meet fluctuating demands without compromising quality.
  • Price and Logistics: Competitive pricing combined with reliable logistics support expedites supply chain stability.
  • Market Certification: WHO prequalification enhances marketability in developing countries.
  • Traceability and Transparency: Suppliers providing comprehensive documentation facilitate regulatory audits and quality control.

Regulatory Landscape and Impact on Suppliers

The regulatory environment heavily influences supplier operations. WHO prequalification programs, FDA approvals, and EMA compliance benchmarks serve as quality indicators. Suppliers meeting these standards can access global markets more efficiently, especially in international aid and procurement programs.

Furthermore, the global push for antibiotic stewardship and safety ensures that suppliers maintain strict testing, sterilization, and expiry protocols. Non-compliance risks market exclusion, legal penalties, and reputational damage.


Market Dynamics and Supply Chain Trends

  • The rise of generic manufacturers in emerging markets has increased supply availability, often at lower costs.
  • Increasing global demand from hospitals, outpatient clinics, and emerging countries propels production capacities.
  • Supply chain disruptions—highlighted by recent global crises—stress the importance of diversified sourcing.
  • Manufacturers are investing in advanced sterilization and packaging technologies to enhance product stability and shelf life in plastic containers.

Conclusion

The supply chain for gentamicin sulfate in sodium chloride 0.9% in plastic containers is extensive, with key players like Fresenius Kabi, Hospira, Sun Pharma, Sandoz, and Neopharma dominating the global market. These suppliers offer high-quality products, regulatory compliance, and broad distribution networks. Strategic sourcing from these reputable manufacturers ensures reliable supply, regulatory adherence, and competitive pricing, critical for healthcare providers worldwide.


Key Takeaways

  • Leading global suppliers include Fresenius Kabi, Hospira, Sun Pharma, Sandoz, and Neopharma.
  • Regulatory compliance (WHO-GMP, FDA, EMA) remains fundamental in supplier selection.
  • Emerging markets have increased the spectrum of suppliers, often at lower costs.
  • Diversified sourcing mitigates risks associated with supply disruptions.
  • Manufacturers investing in quality standards and certification facilitate market expansion.

FAQs

1. What are the primary factors to consider when sourcing gentamicin sulfate in sodium chloride 0.9%?
Regulatory compliance, manufacturing capacity, pricing, logistics, and quality certifications are critical to ensure product safety, efficacy, and reliable supply.

2. Are there specific regulatory approvals required for international procurement?
Yes. Suppliers should meet WHO-GMP standards and possess certifications such as FDA approval or EMA authorization, especially for export to stringent markets.

3. How does the global supply chain impact the availability of gentamicin sulfate?
Supply chain disruptions, geopolitical factors, and manufacturing capacity influence product availability. Diversification among suppliers mitigates these risks.

4. Can emerging market manufacturers reliably supply quality gentamicin sulfate?
Many emerging market manufacturers adhere to international standards like WHO-GMP, ensuring quality. Buyers should verify certifications and conduct audits where necessary.

5. What is the significance of WHO prequalification for gentamicin sulfate manufacturers?
WHO prequalification facilitates acceptance in international procurement programs, aids in regulatory approvals, and signifies adherence to quality and safety standards.


References

  1. [1] World Health Organization. Prequalification of Medicines Programme. Retrieved from WHO website.
  2. [2] U.S. Food and Drug Administration. Current Good Manufacturing Practice (CGMP) Regulations.
  3. [3] European Medicines Agency. Certification and authorization standards for injectable medicines.
  4. [4] Company websites and official product catalogs of Fresenius Kabi, Hospira, Sun Pharma, Sandoz, and Neopharma.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.